Skip to main content
Premium Trial:

Request an Annual Quote

Helicos Snags Steve Lombardi from Affy; Wellcome Trust's Michael Morgan Joins Genome Canada as CSO; Accelrys' CFO Resigns; and Others

NEW YORK, June 16 (GenomeWeb News) - Steve Lombardi has joined Helicos BioSciences as senior vice president of marketing.

 

Lombardi most recently served as a senior vice president at Affymetrix, where he was responsible for corporate development, product R&D and marketing, and corporate marketing between 2002 and 2006.

 

Prior to Affymetrix, Lombardi worked for 16 years at Applied Biosystems as a marketing manager and as an executive. From 1989 to 1998, Lombardi managed ABI's DNA sequencing and genetic analysis business.


Genome Canada has appointed Michael Morgan as chief scientific officer.

 

Morgan was formerly chief executive of the Wellcome Trust Genome Campus. He graduated in biochemistry from TrinityCollege, Dublin, and obtained his PhD from LeicesterUniversity for studies of microbial carbohydrate metabolism. He joined the Wellcome Trust in 1983.

 

At the Wellcome Trust, Morgan was responsible for the development of several initiatives, including the International Human Genome Sequencing Project, the Mouse Sequencing Project, the UK Synchrotron, DIAMOND, the SNP Consortium, and the Structural Genomics Consortium.


David Sankaran is resigning as senior vice president and chief financial officer of Accelrys, the company said this week.

 

Sankaran will continue in his role and assist the company with the search for a new CFO until Aug. 31.


Ciphergen Biosystems has established a scientific advisory board with five members:

Robert Bast, vice president for translational research and a professor at the University of Texas MD Anderson Center; Daniel Chan, a professor of pathology, oncology, urology, and radiology, and the director of the Center for Biomarker Discovery at the Johns Hopkins University School of Medicine; Ian Jacobs, director of the Department of Gynecological Oncology and the Institute of Women's Health at University College London; Joyce Schwartz, vice president and chief laboratory officer of Quest Diagnostics; and William Wallen, senior vice president and chief scientific officer of Idexx Laboratories.


Rob Martienssen, a faculty member of Cold Spring Harbor Laboratory and scientific co-founder of Orion Genomics, has been appointed a Fellow of the Royal Society of London.

 

Martienssen was elected to the society "in recognition of his outstanding contributions to understanding epigenetic control of gene expression," according to a statement from Orion.  

 

Martienssen received his BA in Natural Sciences (Genetics) from CambridgeUniversity, and his PhD from the Plant Breeding Institute and CambridgeUniversity.


Matritech has elected Bruce Lehman to its board of directors. Lehman is the co-founder and CEO of LehmanMillet, a marketing services firm for the medical device and diagnostics industry.

 

Lehman has been a member of the Biomedical Marketing Association since 1982, a member of its board of directors since 1996, president in 2004-2005, and currently serves as immediate past president. He was invited to join the Harvard-MIT Division of Health Sciences and Technology (HST) Advisory Council in 2001 and has served on the HST Advisory Board since 2003.


Alnylam Pharmaceuticals has appointed Saraswathy (Sara) Nochur to the position of vice president of regulatory affairs.

 

Nocur was most recently vice president of regulatory affairs at The Medicines Company. Prior to that, she held positions in regulatory affairs at CereMedix, BioTrack, and DynaGen.


David Gelfand has joined the scientific advisory board of Innovative Biosensors.

 

Gelfand most recently served as vice president of discovery research at Roche Molecular Systems. Prior to that, he was with Cetus, where he founded the company's recombinant molecular research division in 1976.


Evan Jones will retire as chairman and CEO of Digene during the company's 2007 fiscal year, the company said this week.  

 

Jones will remain a member of the Digene board of directors.

 

The board's nominating and corporate governance committee is overseeing the search for a new CEO, "and is in the process of retaining an executive search firm to conduct this search," the company said

The Scan

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.

Study Points to Benefits of Local Consolidative Therapy, Targeted Treatments in Cancer Care

In JCO Precision Oncology, researchers report that local consolidative therapy combined with molecularly targeted treatments could improve survival for some lung cancer patients.

Genetic Variants That Lower LDL Cholesterol Linked to Reduced Heart Disease Risk

Rare variants in two genes that lower LDL cholesterol are also associated with a decreased risk of coronary heart disease, according to a new JAMA Cardiology study.

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.